Bader Elder, DO
Pain Medicine · Dearborn, MINPI 1619538881
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,412 of the $6,298 with a category attached, or 70.1%. 13 manufacturers reported payments, led by Abbott at 40.1% of the total. Reporting peaked in 2023 at $3,832 and has fallen 95.1% since, to $186 in 2025.
Across 50 payments — averaging $125.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Medtronic$2K
- Bard Peripheral Vascular, Inc.$1K
- Vertos Medical, Inc.$165
- Si-bone, Inc.$150
- DJO, LLC$136
- plus $353 from 7 others
What the payments were for
- Travel & lodging$4,41270%
- Food & beverage$1,88630%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 11 | $2,526 |
| Medtronic | 12 | $1,790 |
| Bard Peripheral Vascular, Inc. | 9 | $1,177 |
| Vertos Medical, Inc. | 1 | $165 |
| Si-bone, Inc. | 1 | $150 |
| DJO, LLC | 2 | $136 |
| Cardiovascular Systems Inc. | 7 | $132 |
| Nevro Corp. | 1 | $122 |
| AbbVie | 2 | $35 |
| Inari Medical, Inc. | 1 | $21 |
| Vertex | 1 | $16 |
| Electronic Waveform Lab, Inc. | 1 | $15 |
| GSK | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$2,373
- INTELLIS ADAPTIVESTIM$1,348
- Venclose Maven Catheter$1,063
- mild Device Kit$165
- Omnia$122
How this compares
$6,298 in reported general payments places this provider in the 70th percentile of 139 pain medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 13 | $56 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Dearborn
- Harry SukumaranRochester Hills$304K
- Nasir KhatriFlint$133K
- Yijia ChuGrand Rapids$88K
- Mark MounayerSouthfield$85K
- Jeffrey RosenbergCanton$44K
- Alexander TurfeWyandotte$41K
- Kendall GroseWyandotte$26K
- Craig HartrickRoyal Oak$26K
- Patrick ForrestAnn Arbor$23K
- Anmar DalatiDetroit$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.